Neonious Biotech
incentivize large numbers of people to form the Neonious Network, a group of
computers which will perform the molecular dynamics simulations, by distributing
newly generated MDSIMs among these people based on the computing power they
provide to the cause. With the molecular dynamics simulations, Neonious Biotech
will power Alzheimer and dementia research.
-
1 MDSIM=0.1 USD
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
О проекте Neonious Biotech
We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.
To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.
Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).
Neonious is contracted to help to assess a drug for safety and adverse reactions.
Besides manual analysis, Neonious' research team utilizes computational pipelines
These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.
Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.
This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.
We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.
For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources
Техническая информация
https://github.com/neonious/WelcomeToCodeRepository
Neonious Biotech Roadmap
-
25/05/2021
-
Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
ordered, the cheaper the tokens are. -
01/07/2021
-
Extensively tested Neonious MD software available on GitHub (source code) and for
download (Windows, macOS and Linux). May be used on testing network to generate new
testing tokens. -
01/09/2021
-
Neonious MD software and mining contract passed security audit, results are published.
Neonious Biotech starts the full ICO, preferably with a major exchange. -
31/10/2021
-
Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
anyone on Uniswap by setting up an adequate liquidity pool. -
01/11/2021
-
Neonious Biotech will start helping people set up their systems with the Neonious MD
software to scale the Neonious Network. -
01/01/2022
-
Start of actual molecular dynamic simulations targeting dementia.
-
Early 2022
-
We plan to have reached an agreement for the Neonious Token to be listed at a major
exchange.
Neonious Biotech Команда
Проверено 0%
Внимание. Существует риск того, что непроверенные члены на самом деле не являются членами команды
Neonious Biotech Последние Новости
- Поскольку могут существовать временные различия в обновлениях информации, точная информация о каждом проекте ICO должна проверяться через его официальный веб-сайт или другие каналы связи.
- Эта информация не является предложением или советом по инвестированию в финансирование ICO. Пожалуйста, тщательно изучите соответствующую информацию самостоятельно и примите решение об участии в ICO.
- Если вы считаете, что существуют проблемы или проблемы, которые необходимо исправить в этом контенте, или если вы хотите представить свой собственный проект ICO для включения в список, напишите нам.
